Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma

BACKGROUND: Precision medicine promises to improve prognosis of patients affected by untreatable diseases. Patients with lung cancer (especially lung adenocarcinoma) bear an increased risk of VTE. Mutations in the EGFR and rearrangement in the ALK genes identify specific subgroups of patients. Aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidsson, Elsa, Murgia, Nicola, Ortiz-Villalón, Cristian, Wiklundh, Emil, Sköld, Magnus, Kölbeck, Karl Gustav, Ferrara, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447302/
https://www.ncbi.nlm.nih.gov/pubmed/28560038
http://dx.doi.org/10.1186/s40248-017-0097-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447302/
https://www.ncbi.nlm.nih.gov/pubmed/28560038
http://dx.doi.org/10.1186/s40248-017-0097-0

Ejemplares similares